Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus

Fig. 2

Adjusted hazard ratio (HR) of TB development according to cumulative dose of metformin. *Adjusted for age, sex, the use of insulin, sulfonylurea, other anti-diabetic treatment excluding metformin, systemic corticosteroid, other immunosuppressants, and comorbidities including malignancy, malabsorption, CKD, dialysis, gastrectomy, HIV/AIDS and organ transplantation, CCI, number of hospitalization, and outpatient visit days. HR = hazard ratio; CI = confidence interval; CKD = chronic kidney disease; CCI = charlson comorbidity index

Back to article page